Literature DB >> 16978957

Long-term outcomes of malignant phyllodes tumors patients: an institutional experience.

Adora Fou1, Freya R Schnabel, Diane Hamele-Bena, Xiao-Jun Wei, Bin Cheng, Mahmoud El Tamer, Laura Klein, Kathie Ann Joseph.   

Abstract

BACKGROUND: Malignant phyllodes tumors are an extremely rare breast tumor. Prognostic features and overall survival data have not been consistent across studies.
METHODS: Retrospectively, we examined the clinicopathologic features of 27 breast cancer patients treated for malignant phyllodes tumors from 1995 to 2004 and analyzed their recurrence and survival outcomes using contingency tables, a logistic regression model, or a proportional hazard model.
RESULTS: The mortality rate was 12% (n = 3) of the cohort and 75% of the group with distant metastases. The median follow-up period was 51 months (range, 12-192 mo). A mitotic index greater than 10 per high-powered field, the presence of stromal overgrowth, mastectomy at initial surgery, and larger tumor size were associated with an increased incidence of distant metastases. Larger tumor size also was associated with an increased incidence of death.
CONCLUSIONS: Most patients with malignant phyllodes tumors will enjoy significant long-term survival if treated appropriately with local excision with clear margins.

Entities:  

Mesh:

Year:  2006        PMID: 16978957     DOI: 10.1016/j.amjsurg.2006.06.017

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  17 in total

1.  Surgical treatment of giant recurrent breast phyllodes tumor.

Authors:  Xiru Li; Yungong Yang; Jiandong Wang; Bing Ma; Yuanchao Jin; Rong Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

Review 2.  Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence.

Authors:  Zhi-Rui Zhou; Chen-Chen Wang; Zhao-Zhi Yang; Xiao-Li Yu; Xiao-Mao Guo
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  The occurrence of rare cancers in U.S. adults, 1995-2004.

Authors:  Robert T Greenlee; Marc T Goodman; Charles F Lynch; Charles E Platz; Lori A Havener; Holly L Howe
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

Review 4.  Width of margins in phyllodes tumors of the breast: the controversy drags on?-a systematic review and meta-analysis.

Authors:  Arnaud Toussaint; Romain Piaget-Rossel; Coraline Stormacq; Patrice Mathevet; Karine Lepigeon; Patrick Taffé
Journal:  Breast Cancer Res Treat       Date:  2020-09-15       Impact factor: 4.872

5.  Metastatic Malignant Phyllodes Tumor of the Breast: An Aggressive Disease-Analysis of 7 Cases.

Authors:  Pooja Ramakant; Marie M Therese; M J Paul
Journal:  Indian J Surg Oncol       Date:  2015-03-18

6.  A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.

Authors:  Richard J Barth; Wendy A Wells; Sandra E Mitchell; Bernard F Cole
Journal:  Ann Surg Oncol       Date:  2009-05-08       Impact factor: 5.344

7.  Aggressive palliative surgery in metastatic phyllodes tumor: impact on quality of life.

Authors:  A S Kapali; M Singh; Svs Deo; N K Shukla; Dillip K Muduly
Journal:  Indian J Palliat Care       Date:  2010-05

Review 8.  Phyllodes Tumors: A Scoping Review of the Literature.

Authors:  Jessica Bogach; Saad Shakeel; Frances C Wright; Nicole J Look Hong
Journal:  Ann Surg Oncol       Date:  2021-07-22       Impact factor: 5.344

9.  Lumps, bumps and GI bleeding.

Authors:  Michael Perry; Nicholas Kelly; Maurice Loughrey; Michael Hyland; Grant Caddy
Journal:  Ulster Med J       Date:  2012-01

10.  Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities.

Authors:  Denis L Fontes Jardim; Anthony Conley; Vivek Subbiah
Journal:  Orphanet J Rare Dis       Date:  2013-07-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.